Combined Cytokine Blockade Therapy (CCBT) Using Basiliximab and Infliximab for Treatment of Steroid-Refractory Graft-Versus-Host Disease (SR-GvHD).
Pourhassan H, Nguyen T, Yang D, Otoukesh S, Arslan S, Blackmon A, Agrawal V, Amanam I, Ball B, Koller P, Salhotra A, Aribi A, Becker P, Curtin P, Artz A, Aldoss I, Ali H, Stewart F, Smith E, Stein A, Marcucci G, Forman SJ, Nakamura R, Al Malki MM.
Pourhassan H, et al. Among authors: stewart f.
Cancers (Basel). 2024 Nov 22;16(23):3912. doi: 10.3390/cancers16233912.
Cancers (Basel). 2024.
PMID: 39682101
Free PMC article.